EGFR-IN-168
EGFR-IN-168 (Compound 9a) is a potent EGFR inhibitor with an IC50 of 0.069 μM. EGFR-IN-168 has antitumor activity[1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(/C=C/C1=CC=C(C=C1)F)C2=NC3=C(C=CC=C3)N2CC4=CN([C@@H]5[C@@H](O)[C@H](O)[C@H](O)[C@H](CO)O5)N=N4
Molecular Formula
C25H24FN5O6
Molecular Weight
509.49
References & Citations
[1]Srour AM, et al. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025 Jul 15;15 (1) :25514.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
132032-APC 100 µL
PTGIS (Prostacyclin Synthase, Prostaglandin I2 Synthase, CYP8, CYP8A1, MGC126858, MGC126860) (APC)
Ask
View Details